More funding needs to go into pediatric diffuse intrinsic pontine glioma or “DIPG,” an untreatable brain cancer. When stories of three-year old children losing their life to such a condition surface, TrialSite News springs to action directing supporters to the family...
Cancer
Category
Oncology Research Patients: No Longer a Need to Cross the Bridge into Manhattan for Superior Cancer Treatment
Private equity-backed OneOncology is on the move again as a leading national cancer practice, New York Cancer & Blood Specialists (NYCBS), inked a partnership deal with The Brooklyn Hospital Center (TBHC), an independent community hospital in the quest to build a...
Top Oncology Investigator Dr. Anthony Tolcher (Next Oncology) Selected by Heat Biologics to Lead Novel Phase I Oncology Study
Anthony Tolcher, MD, FRCPC, a medical oncologist and co-founder of research organization NEXT Oncology has been appointed the lead investigator for a Phase I clinical trial investigating Heat Biologics’ investigational therapy called PTX-35, a novel potential...
‘It Must be Witchcraft’ as Harry M Reid’s Life Saved by Combination Therapy Delivered by the ‘Unconventional’ Dr. Patrick Soon-Shiong
At 80 years old, former U.S. Senator Harry M. Reid’s struggle with pancreatic cancer was close to the end. But the ex-boxer and hard-scrabble fighter that he is propelled him to survive despite the extremely low odds: he is now spending time with his adult children...
Dr. Heather Cheng at Fred Hutch Secures NCI Grant to Help Patients ‘Crack the Code’
Clinical trial transparency, accessibility and availability represents a trend TrialSite News was formed to promote and contribute towards, and recently a prestigious research center in the Pacific Northwest, Fred Hutch, will seek to contribute in powerful ways to...
HUS & University of Helsinki Receive $1.7m For Advanced Clinical Breast Cancer Study
The Hus Comprehensive Cancer Center will support a VeMA clincial breast cancer trial thanks to a $1.7 million grant from the Finnish Jane and Aatos Erkko Foundation. This award funds a long-term translational collaboration project between breast cancer researchers at...
Australian Government Injects $13.6m to Fund 10 Clinical Trials to Find Innovative Cancer Treatments
Australia’s Department of Health now offers $13.6 million to support 10 clinical trials researching innovative cancer treatments including melanoma, reproductive and gynecological cancers and childhood brain cancer. Accomplished via the Medical Research Future Fund,...
MD Anderson Resumes Phase Ib Clinical Trial of Investigational Cancer Therapy
MD Anderson Cancer Center (“MDACC”) has resumed its investigator-initiated trial of an early stage pancreatic cancer therapy called SOR-C13 developed by a clinical-stage company called Sorcimed. In February, Sorcimed announced that MDACC completed the first cohort of...
Purdue Spinoff Targeting AML Secures $2m SBIR Grant to Fast Track Cancer Drug Platform Technology
One of the most lethal of cancers, acute myeloid leukemia (AML) afflicts over 19,000 people per year accompanied by 11,000 annual deaths reports the American Cancer Society. Recently, the National Cancer Institute awarded a SBIR Phase I/II grant to KinaRx LLC, a...
University of Birmingham Cancer Research Receives Funding for Neuroblastoma Clinical Trial for Children
The University of Birmingham Cancer Research UK Clinical Trials Unit is the UK national coordinator for the ten-year SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2), a Phase III clinical trial to assess potential treatment pathways for children diagnosed...
OneOncology on the Move in New York Partnering with New York Cancer and Blood Specialists & Fueling Growth
OneOncology, a national partnership of independent community oncologists, recently announced that four oncology practices in Queens and Manhattan selected to join New York Cancer and Blood Specialists (NYCBS). Hence this firm is one the move, helping partner practices...
Shanghai Zhongshan Hospital Leads PREDICT Trial to Validate Early Stage Cancer Detection Trial
Shanghai Zhongshan Hospital and other sites across China have been recruiting by Burning Rock to initiate the 14,000 patient PREDICT (Pan-CancerR Early Detection ProjecCT) study to further developing and validate its pan-cancer early detection technology. This...
MACC Fund Receives $1 Million Gift
Even as the world’s focus has shifted to fighting the COVID-19 pandemic, the critically important battle against childhood cancer has picked up a bit of momentum. Today, the Midwest Athletes Against Childhood Cancer, Inc. (MACC Fund) announced the acceptance of a $1...
Compugen Presents Data Update from Ongoing Phase 1 Trial of COM701 at the 2020 AACR Virtual Annual Meeting
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, presented updated results from its ongoing Phase 1 dose escalation study of COM701, a first-in class anti-PVRIG antibody, in patients with advanced...
Multicenter Study on the Risks of COVID-19 to Cancer Patients
Patients with hematological and other cancers as well as recipients of haematopoietic stem cell transplantation (HSCT) face severe risk from COVID-19 due to a number of factors including age, multiple comorbidities as well as immunosuppressed condition due to their...
New Drug Approved for Rare Cancer Called Cholangiocarcinoma
The U.S. Food and Drug Administration approved Incyte’s pemigatinib (Pemazyre) on Friday for previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements. A rare cancer of the bile ducts, Cholangiocarcinoma occurs in...
ASCO Launches New COVID-19-Driven Cancer Registry Leveraging CancerLinQ® and mCODE™
The American Society of Clinical Oncology (ASCO) launched a patient registry to help the cancer community better understand 1) how cancer patients are impacted by COVID-19, and 2) what are the disruptions to cancer care due to the global pandemic. Called the ASCO...
Yale Cancer Center Study Indicates Pembrolizumab Might Extend Survival of Lung Cancer Patients with PD-L1 Biomarker
In a study funded by Yale Cancer Center and Merck, investigators learned that in about 25% of patients with an advanced form of lung cancer, it spreads to the brain. Thus far, the only way to combat such a situation is with radiation. However, consequences of such...
COVID-19 Pandemic & Cancer Trials: National Clinical Trials Network Evolves & Adjusts for New Reality
Funded and managed by the National Cancer Institute, the National Clinical Trials Network (NCTN) represents critical infrastructure including investigators for over 2,200 cancer clinical investigational sites across the United States in support of cancer...
Top Investigator at Roswell Park Comprehensive Cancer Center Secures $14.5m from NCI for 5 Clinical Trials
Roswell Park Comprehensive Cancer Center (NCI) clinical investigator Pawel Kalinski secured a five-year, $14.54 million award from the National Cancer Institute (NCI) to expand a promising immunotherapy platform. The National Cancer Institute (NCI)-based grant will...